Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

The impact of blood glucose and HbA(1c) goals on glycaemic control in children and adolescents with Type 1 diabetes.

Boot M, Volkening LK, Butler DA, Laffel LM.

Diabet Med. 2013 Mar;30(3):333-7. doi: 10.1111/dme.12083.

2.

Does family cohesiveness and parental alexithymia predict glycaemic control in children and adolescents with diabetes?

Meunier J, Dorchy H, Luminet O.

Diabetes Metab. 2008 Nov;34(5):473-81. doi: 10.1016/j.diabet.2008.03.005. Epub 2008 Sep 9.

PMID:
18783976
4.

The influence of structure, process, and policy on HbA(1c) levels in treatment of children and adolescents with type 1 diabetes.

Hanberger L, Samuelsson U, Berterö C, Ludvigsson J.

Diabetes Res Clin Pract. 2012 Jun;96(3):331-8. doi: 10.1016/j.diabres.2012.01.016. Epub 2012 Feb 11.

PMID:
22326692
5.

The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes.

Lind M, Olsson M, Rosengren A, Svensson AM, Bounias I, Gudbjörnsdottir S.

Diabetologia. 2012 Nov;55(11):2946-53. doi: 10.1007/s00125-012-2681-3. Epub 2012 Aug 16.

PMID:
22895807
6.

High normal HbA(1c) levels were associated with impaired insulin secretion without escalating insulin resistance in Japanese individuals: the Toranomon Hospital Health Management Center Study 8 (TOPICS 8).

Heianza Y, Arase Y, Fujihara K, Tsuji H, Saito K, Hsieh SD, Kodama S, Shimano H, Yamada N, Hara S, Sone H.

Diabet Med. 2012 Oct;29(10):1285-90. doi: 10.1111/j.1464-5491.2012.03667.x.

PMID:
22486679
7.

Care delivery and outcomes among Belgian children and adolescents with type 1 diabetes.

Doggen K, Debacker N, Beckers D, Casteels K, Coeckelberghs M, Dooms L, Dorchy H, Lebrethon M, Logghe K, Maes M, Massa G, Mouraux T, Rooman R, Thiry-Counson G, Van Aken S, Vanbesien J, Van Casteren V.

Eur J Pediatr. 2012 Nov;171(11):1679-85. doi: 10.1007/s00431-012-1809-2. Epub 2012 Aug 9.

PMID:
22875314
8.

Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA(1c) and impaired fasting glucose: the Toranomon Hospital Health Management Center Study 4 (TOPICS 4).

Heianza Y, Arase Y, Fujihara K, Tsuji H, Saito K, Hsieh SD, Kodama S, Shimano H, Yamada N, Hara S, Sone H.

Diabet Med. 2012 Sep;29(9):e279-85. doi: 10.1111/j.1464-5491.2012.03686.x.

PMID:
22510023
9.

Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.

Blonde L, Merilainen M, Karwe V, Raskin P; TITRATE Study Group.

Diabetes Obes Metab. 2009 Jun;11(6):623-31. doi: 10.1111/j.1463-1326.2009.01060.x.

PMID:
19515182
10.
11.

Good metabolic control is associated with better quality of life in 2,101 adolescents with type 1 diabetes.

Hoey H, Aanstoot HJ, Chiarelli F, Daneman D, Danne T, Dorchy H, Fitzgerald M, Garandeau P, Greene S, Holl R, Hougaard P, Kaprio E, Kocova M, Lynggaard H, Martul P, Matsuura N, McGee HM, Mortensen HB, Robertson K, Schoenle E, Sovik O, Swift P, Tsou RM, Vanelli M, Aman J.

Diabetes Care. 2001 Nov;24(11):1923-8.

PMID:
11679458
12.

HbA(1c) as a diagnostic tool for diabetes and pre-diabetes: the Bangladesh experience.

Bhowmik B, Diep LM, Munir SB, Rahman M, Wright E, Mahmood S, Afsana F, Ahmed T, Khan AK, Hussain A.

Diabet Med. 2013 Mar;30(3):e70-7. doi: 10.1111/dme.12088. Erratum in: Diabet Med. 2016 Feb;33(2):271.

PMID:
23199158
13.

Diabetes Mellitus in German Primary Care: quality of glycaemic control and subpopulations not well controlled - results of the DETECT study.

Huppertz E, Pieper L, Klotsche J, Stridde E, Pittrow D, Böhler S, Lehnert H.

Exp Clin Endocrinol Diabetes. 2009 Jan;117(1):6-14. doi: 10.1055/s-2008-1073127. Epub 2008 May 9.

PMID:
18465681
14.

HbA(1c) in adults without known diabetes from southern Europe. Impact of the new diagnostic criteria in clinical practice.

Bernal-Lopez MR, Santamaría-Fernandez S, Lopez-Carmona D, Tinahones FJ, Mancera-Romero J, Peña-Jimenez D, Jansen-Chaparro S, Baca-Osorio AJ, Cuesta-Muñoz AL, Serrano-Rios M, Gomez-Huelgas R.

Diabet Med. 2011 Nov;28(11):1319-22. doi: 10.1111/j.1464-5491.2011.03317.x. Epub 2011 Apr 16.

PMID:
21966956
15.

Short-term impact of HbA1c on morbidity and all-cause mortality in people with type 2 diabetes: a Danish population-based observational study.

Skriver MV, Støvring H, Kristensen JK, Charles M, Sandbæk A.

Diabetologia. 2012 Sep;55(9):2361-70. doi: 10.1007/s00125-012-2614-1. Epub 2012 Jun 27.

PMID:
22736395
16.

Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.

Konya J, Ng JM, Cox H, Cooke M, Lewis N, Bhandari S, Atkin SL, Kilpatrick ES.

Diabet Med. 2013 Oct;30(10):1250-4. doi: 10.1111/dme.12249. Epub 2013 Jul 9.

PMID:
23758176
17.

Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy.

Shalitin S, Gil M, Nimri R, de Vries L, Gavan MY, Phillip M.

Diabet Med. 2010 Mar;27(3):339-47. doi: 10.1111/j.1464-5491.2009.02925.x.

PMID:
20536498
18.

Predictive value of HbA1c for incident diabetes among subjects with impaired glucose tolerance--analysis of the Indian Diabetes Prevention Programmes.

Ramachandran A, Snehalatha C, Samith Shetty A, Nanditha A.

Diabet Med. 2012 Jan;29(1):94-8. doi: 10.1111/j.1464-5491.2011.03392.x.

PMID:
21790773
19.

Illness perceptions and glycaemic control in diabetes: a systematic review with meta-analysis.

Mc Sharry J, Moss-Morris R, Kendrick T.

Diabet Med. 2011 Nov;28(11):1300-10. doi: 10.1111/j.1464-5491.2011.03298.x. Review.

PMID:
21418098
20.

Point-of-care testing of HbA1c and blood glucose in a remote Aboriginal Australian community.

Martin DD, Shephard MD, Freeman H, Bulsara MK, Jones TW, Davis EA, Maguire GP.

Med J Aust. 2005 May 16;182(10):524-7. Erratum in: Med J Aust. 2005 Jun 20;182(12):656. Bulsara, Max K [added].

PMID:
15896181

Supplemental Content

Support Center